Cannabis

Medical cannabis in chronic pain management

Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.

COVID-19 and medical cannabis: Could the crisis bring opportunities?

John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.

Measuring heavy metals in cannabis and hemp

Here, Robert Thomas, Principal Consultant, Scientific Solutions, highlights the importance of measuring metals in cannabis and hemp.

Health Canada: Legalising edible cannabis products

Health Canada led the world in large-scale cannabis legalisation and is now creating regulation for edible cannabis products: What is next?

Cannabinoid products: Create the best organic hemp products for the mass market

A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.

Growing pains: Creating value in the maturing cannabis market

Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.

Medical cannabis vaporizers

Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.

EU crackdown: Novel food regulation of CBD

Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.

Why patient advocates are key to growing CBD brands

Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.

Up in smoke: Understanding knowledge gaps for cannabis edibles

Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.

The cultivation of sustainable and organic medical cannabis in controlled environments

CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.

Sovereignport discuss their CBD and Hemp supply chain

Speaking with Sarah Yetman, CEO of Sovereignport, we understand how she pioneered a CBD and hemp supply chain that is surviving COVID-19 measures.

Cannyx Markets UK Ltd: The globalisation of the CBD industry

Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.

Professor Mike Barnes: The future of medical cannabis is real

We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.

Cannabinoids in medicine part 4: Epilepsy

In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.

Malta’s stance on cannabis for medicinal and research purposes

Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.

Setting global standards for CBD quality and compliance

At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders